Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.
A. Byrne (Sydney (NSW), Australia), R. Wong (Sydney (NSW), Australia), D. Marriott (Sydney (NSW), Australia), D. Kocic (Sydney (NSW), Australia), J. Alffenaar (Sydney (NSW), Australia), J. Cho (Sydney (NSW), Australia), B. Marais (Sydney (NSW), Australia)
Source: International Congress 2022 – Advances in the treatment and clinical/surgical management of tuberculosis and NTM
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Byrne (Sydney (NSW), Australia), R. Wong (Sydney (NSW), Australia), D. Marriott (Sydney (NSW), Australia), D. Kocic (Sydney (NSW), Australia), J. Alffenaar (Sydney (NSW), Australia), J. Cho (Sydney (NSW), Australia), B. Marais (Sydney (NSW), Australia). Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.. 2630
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|